Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Biotech is now the deepest pocket of leadership in the entire Nasdaq. Of the stocks that currently clear a strict leadership bar - top-decile relative strength, in a confirmed uptrend, liquid, sitting ...
NEW YORK (AP) -- Biotech stocks slipped Tuesday on concerns about patent protection overseas and on continued scrutiny of the cost of some medications. The S&P 500's biotech index slid 4 percent in ...
X4 Pharmaceuticals is rated BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending into 2028. XFOR's primary value lies in its 4WARD Phase 3 trial in ...
BIO, the world’s largest trade group for the biotechnology industry, has gone from trying to water down proposed US legislation to sever ties with Chinese health care companies, to supporting it.
Hundreds of companies and thousands of scientists, from lone entrepreneurs to the employees of large firms, are finding strength in numbers and a common voice for their political and professional ...
Later this month, BIO will hold its annual conference. BIO provides advocacy, business development, and communications services for its members worldwide. BIO came into existence in 1993 through the ...
In the rapidly evolving biotech and life sciences sectors, the importance of trade secrets has grown significantly. Companies are investing heavily in research and development to create cutting-edge ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A San Diego trade group seeking to boost the Southern California biotech industry is now setting up shop in downtown Los Angeles, a northward shift that could step on the toes of L.A.’s own homegrown ...
Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as a global biotech hub Legend Biotech received ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果